Sign up for free insights newsletter
BG

Qilian International Holding Group Limited

BGMUnited States

Need professional-grade analysis? Visit stockanalysis.com

$0.60
-30.80%
End of day
Market Cap

$202.63M

P/E Ratio

N/A

Employees

298

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.71-0.96-1.12-0.79-0.92
Calmar-1.16-1.05-0.98-0.53-0.90
Sharpe-0.67-0.91-0.85-0.51-0.73
Omega0.330.340.660.950.61
Martin-1.87-1.70-1.78-0.76-1.48
Ulcer53.4658.6953.0567.7058.76

Qilian International Holding Group Limited (BGM) Price Performance

Qilian International Holding Group Limited (BGM) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $0.60, down 30.80% from the previous close.

Over the past year, BGM has traded between a low of $0.60 and a high of $16.36. The stock has lost 94.6% over this period. It is currently 96.3% below its 52-week high.

Qilian International Holding Group Limited has a market capitalization of $202.63M.

About Qilian International Holding Group Limited

BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$46.47M
EBITDA
$-2,373,423
Profit Margin
-26.32%
EPS (TTM)
-0.29
Book Value
1.85

Technical Indicators

52 Week High
$17.17
52 Week Low
$0.60
50 Day MA
$2.25
200 Day MA
$7.45
Beta
1.46

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
6.78
Price/Book
1.09
Enterprise Value
$185.86M